Fernández Vega - Autor del contenido
OPHTHALMOLOGICAL INSTITUTE   OPHTALMOLOGICAL RESEARCH FOUNDATION   UNIVERSITY INSTITUTE   FERNÁNDEZ-VEGA FOUNDATION  Do we call you?
Title Image
You are in:  / Home  /  Articles posted by Fernandez Vega

Author: Fernandez Vega

  RESEARCHER: Dr. Jesús Merayo Lloves  RECLUTANDO    "Double-blind, placebo-controlled phase I / II study to assess the efficiency and safety of AVX012 ophthalmic solution in subjects with mild to moderate dry eye" INDICATION: Pacientes con ojo seco leve o moderado TREATMENT: AVX-012 PROMOTOR: Avizorex Pharma

  RESEARCHER: Prof. Luis Fernández-Vega Sanz  RECLUTANDO    A dose-Ranging, Muti-Centre, Randmised, Double-Mased, Sham-Controlled, Parallel-Group Study of the Efficacy and safety of Opt-302 in Combination wiht Ranibizumab Compared with Ranibizumab Alone, in Patients with Neovascular Age-Related Macular Degeneration ( Wet AMD) INDICATION: Pacientes con degeneración macular

  RESEARCHER: Dr. Álvaro Fernández-Vega Sanz  ACTIVO    Phase IV, randomized, double-blind, simulated control study for the efficacy, safety, and tolerability of Aflibercept intravitreal monotherapy compared to Aflibercept and Concomitant Photodynamic Therapy in patients with Polypoidal Choroidal Vasculopathy. (ATLANTIC) INDICATION: Patients with polypoid choroidal vasculopathy TREATMENT: Aflibercept PROMOTOR: AIBILI